By
Drug Target Review2025-10-29T10:28:41
Scientists have identified an overactive brain cell type linked to schizophrenia-like symptoms in mice – a discovery that could lead to new, targeted treatments to prevent cognitive impairments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-07-04T10:05:58
Sponsored by Revvity
2023-09-27T13:56:39
Sponsored by Euretos
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2023-06-29T09:19:53
Sponsored by BMG Labtech GmbH
Site powered by Webvision Cloud